Singapore Med J 2013; 54(3): e50-e52; http://dx.doi.org/doi:10.11622/smedj.2013057
A case of linear morphoea mistaken for reflex sympathetic dystrophy
Thng TG, Wong KY
Correspondence: Dr Steven Thng, steventhng@nsc.gov.sg
ABSTRACT
Morphoea, or localised scleroderma, is a disease entity with poorly understood pathogenesis. Early diagnosis of the condition is crucial in order to prevent permanent morbidity. However, initial presentations of morphoea can be nonspecific and easily mistaken for other conditions, resulting in late treatment and permanent disability. We report a case of linear morphoea in a 22-year-old man who was initially diagnosed with reflex sympathetic dystrophy. By the time the diagnosis of morphoea was confirmed, the patient had already developed contractures.
Keywords: contractures, linear morphoea, reflex sympathetic dystrophy
Singapore Med J 2013; 54(3): e50–e52; doi:10.11622/smedj.2013057
REFERENCES
1. Peterson LS, Nelson AM, Su WP, et al. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 1997; 24:73-80.
PMid:9002014 |
| |
2. Murray KJ, Laxer RM. Scleroderma in children and adolescents. Rheum Dis Clin North Am 2002; 28:603-24.
http://dx.doi.org/10.1016/S0889-857X(02)00010-8 |
| |
3. Leitenberger JJ, Cayce RL, Haley RW, et al. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol 2009; 145:545-50.
http://dx.doi.org/10.1001/archdermatol.2009.79 |
| |
4. Sehgal VN, Srivastava G, Aggarwal AK, et al. Localized scleroderma/morphea. Int J Dermatol 2002; 41:467-75.
http://dx.doi.org/10.1046/j.1365-4362.2002.01469.x |
| |
5. Fett N, Werth VP. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 2011; 64:217-28.
http://dx.doi.org/10.1016/j.jaad.2010.05.045 |
| |
6. Zulian F, Athreya BH, Laxer R, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford) 2006; 45:614-20.
http://dx.doi.org/10.1093/rheumatology/kei251 |
| |
7. Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol 2006; 18:606-13.
http://dx.doi.org/10.1097/01.bor.0000245727.40630.c3 |
| |
8. Vilela FA, Carneiro S, Ramos-e-Silva M. Treatment of morphea or localized scleroderma: review of the literature. J Drugs Dermatol 2010; 9:1213-9.
PMid:20941945 |
| |
9. Dytoc M, Ting PT, Man J, Sawyer D, Fiorillo L. First case series on the use of imiquimod for morphoea. Br J Dermatol 2005; 153:815-20.
http://dx.doi.org/10.1111/j.1365-2133.2005.06776.x |
| |
10. Kroft EB, Berkhof NJ, van de Kerkhof PC, Gerritsen RM, de Jong EM. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol 2008; 59:1017-30.
http://dx.doi.org/10.1016/j.jaad.2008.07.042 |
| |
11. Fett N, Werth VP. Update on morphea: part II. Outcome measures and treatment. J Am Acad Dermatol 2011; 64:231-42.
http://dx.doi.org/10.1016/j.jaad.2010.05.046 |
| |
